Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TRAW
$0.57
+4.25%
TRAW
· Traws Pharma, Inc.
$0.57
+0.02 (+4.25%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current projections, the Company believes that it does not have sufficient cash and cash equivalents to support its operations for more than one year following the date that these financial statements are issued. As a result of these conditions, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.66M
Shares
15.37M
Volume · Oct 2
69.63K
Avg daily vol (3M)
570.37K
All webcasts
Earnings call · FY2024 Q2
Traws Pharma, Inc. (TRAW) Q2 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$57,000
+0% YoY
Diluted EPS
-$20.52
Net income
-$123.14M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 15, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 15, 2024 · complete as-filed document